senior vice president of Regeneron and head of its Genetics Center. “We don’t have tremendous data platforms in this country, unfortunately, to understand human health and disease,” Baras ...

Aberman was at Regeneron for seven years, rising to the role of senior vice president of investor relations and strategy, having previously worked as a biotech analyst at Credit Suisse and Morgan ...

Schleifer, M.D., Ph.D., Board co-Chair, President and Chief Executive Officer of Regeneron. “Thanks to our long-term and consistent R&D investment, we have – in addition to our four ...

Dr John Lin, senior vice president of immune-oncology and head of bispecifics at Regeneron, said: “The collaboration will enable Regeneron and CytomX to combine our collective oncology expertise ...

The Truveta team at its Bellevue, Wash., headquarters last year. (Truveta Photo) Seattle-area health data company Truveta announced $320 million in ...

M.D., Ph.D., president and chief scientific officer of Regeneron. “By combining Regeneron’s expertise in genetics and drug development with Truveta's extensive phenotypic data and ...

Before Regeneron, it was funded by Intel and before ... and engineers represent the best in the nation,” Maya Ajmera, president of Society for Science, said in a statement.